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Abstract
Background: We have previously reported that ATP treatment of M bovis-BCG infected human
macrophages induces P2X7  receptor-dependent killing of intracellular mycobacteria. The
mechanism mediating this bactericidal effect has not been full characterized but is known to be
Ca2+-dependent and to promote the maturation and acidification of mycobacteria-containing
phagosomes. In this study we demonstrate that the ATP/P2X7-mediated, mycobactericidal effect
also involves the induction of cell autophagy.
Results: We report that 3 mM ATP induces rapid cell autophagy in THP1 cells and monocyte-
derived macrophages within 30 minutes post-treatment, as revealed by the expression of LC3-II
bands on western blot analysis. Using Ca2+-free media and selective P2X7 agonists and antagonists,
ATP-induced cell autophagy was shown to be Ca2+ and P2X7 receptor-dependent. Electron
microscopy of ATP-treated, BCG-infected MDMs revealed the presence of the bacteria within
characteristic double-membraned autophagosomes. Confocal analysis further confirmed that
pharmacological inhibition of autophagy by wortmannin or pre-treatment of macrophages with
anti-P2X7 antibody blocked ATP-induced phago-lysosomal fusion. Induction of cell autophagy with
ATP was also temporally associated with a fall in intracellular mycobacterial viability, which was
suppressed by treatment with wortmannin or the selective P2X7 antagonist, oxidized ATP (oATP).
Conclusion:  We provide the first evidence that ATP/P2X7-mediated killing of intracellular
mycobacteria involves the induction of cell autophagy. The findings support the hypothesis that
autophagy plays a key role in the control of mycobacterial infections.
Background
Tuberculosis continues to be a leading cause of human
mortality and morbidity, with WHO figures estimating a
global prevalence exceeding 14 million and mortality of
approximately 1.6 million in the year 2005 [1]. The con-
tinuing global crisis has become further complicated by
the emergence of multi-drug resistant strains of the bacte-
ria and an increasing population of HIV-infected patients
around the world. In view of this escalating clinical chal-
lenge, there is a growing need to develop novel therapeu-
tic alternatives employing potent mycobactericidal
mechanisms. Hence, there has been a lot of interest in cell
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autophagy as a potential immune defense mechanism
against a number of bacterial pathogens, including myco-
bacteria [2-5]. Physiological or pharmacological induc-
tion of autophagy via cell starvation or treatment with
rapamycin, have been reported to suppress mycobacterial
survival within RAW cells through increased acidification
and maturation of mycobacterial phagosomes [4].
It has been previously reported from our laboratory that
treatment of infected human macrophages with adenos-
ine 5'-triphosphate (ATP) was capable of killing mycobac-
teria by subverting the mycobacterium-induced block in
phago-lysosomal fusion [6,7]. In the light of recent find-
ings, the present study was undertaken to look for evi-
dence of induction of cell autophagy within ATP-treated
macrophages and of a role for this process in mediating its
associated mycobactericidal activity. In this work we dem-
onstrate, for the first time, that ATP induces autophagy in
human macrophages within 30 minutes of exposure,
which was associated with a subsequent decrease in Myco-
bacterium bovis BCG viability within infected cells. We fur-
ther confirmed a role for extracellular Ca2+ and delineated
the identity of the purinergic receptor involved in this
process by using Ca2+-free media and selective purinergic
receptor agonists and antagonists. We were thus able to
confirm that ATP induces rapid cell autophagy and killing
of intracellular mycobacteria within infected human mac-
rophages via a Ca2+-dependent process mediated by acti-
vation of P2X7  receptors. The results support the
importance of autophagy as a mycobactericidal mecha-
nism utilized by human macrophages and provide a pos-
sible rationale for the recently reported P2X7
polymorphisms associated with extra-pulmonary TB [8].
The findings also suggest a potential therapeutic role for
P2X7 agonists in treating mycobacterial infections.
Results
ATP induces autophagy
To determine whether ATP was capable of inducing
autophagy in THP1 cells and monocyte-derived macro-
phages (MDMs), the expression of the microtubule-asso-
ciated (LC3-I) and membrane associated (LC3-II) forms
of LC3 protein were assessed in both ATP-treated and
untreated cells by Western Blot and Confocal microscopy.
The processing of the 18 kDa microtubule-associated
form of LC3 protein (LC3-I) to its 16 kDa, truncated form
(LC3-II), is accepted as one of the standard read-outs of
cell autophagy [9,10]. In Western blot studies, we
observed expression of both LC3-I and LC3-II forms of
LC3 protein in ATP-treated THP1 cells (Figure 1A) and
MDMs, (Figure 1B) as revealed by bands with electro-
phoretic mobility corresponding to molecular masses of
18 kDa and 16 kDa respectively. In contrast, only the 18
kDa LC3-I band was expressed in control non-ATP treated
THP1 or MDM cells (Figures 1A and 1B).
Another commonly used assay for monitoring for the
occurrence of cell autophagy relies on demonstrating by
microscopy the transitional shift of the 18 kDa cytosolic
(microtubule-associated) form of LC3 (LC3-1) to its
membrane-associated, 16 kDa lipidated form, LC3-II on
autophagosomes [9,10]. Using an anti-LC3 antibody, we
observed, by confocal microscopy, an increased transition
of the diffuse cytosolic staining pattern, typical of LC3-I,
(Figure 2A; left panel) to the punctuate staining pattern,
characteristic of LC3-II, within ATP-treated MDMs (Figure
2A; right panel).
ATP-induced autophagy is dependent on mobilization of 
extracellular calcium
We have previously reported that ATP can stimulate Ca2+
entry into cells not only through activation of ionotropic
P2X purinoceptors, but also via mobilisation of intracel-
lular Ca2+ into the cytosol by activation of metabotropic
P2Y receptors [7]. We then sought to establish the relative
contribution of these Ca2+ sources to the induction of
autophagy by examining the cellular response to ATP (3
mM) stimulation for 30 minutes in both Ca2+-containing
and Ca2+-free medium. In cells treated with ATP in Ca2+-
containing media we observed the induction of
autophagy by Western blot analysis as revealed by the
expression of both the 16 kDa and 18 kDa forms of LC3
protein (Figure 1C). In contrast, ATP-induced cell
autophagy was shown to be completely inhibited in Ca2+-
free medium, as revealed by the absence of expression of
the 16 kDa lipidated form of LC3 (LC3-II) (Figure 1C).
ATP-induced autophagy is P2X7 – dependent
Having obtained preliminary evidence of P2X receptor
involvement in ATP-induced cell autophagy from the
above results, we sought evidence that this process
involved P2X7 receptors. We then investigated the induc-
tion/inhibition of autophagy in response to a number of
purinergic receptor agonists and antagonists. It was
observed in Western blot assays (Figure 1D) that
autophagy (LC3-II expression) was not induced following
uridine 5'-triphosphate (UTP) (3 mM) stimulation, which
activates P2Y, but not P2X receptors. In contrast,
autophagy was induced by the ATP analogue, benzoyl-
benzoic ATP (bzATP), which selectively activates P2X7
receptors. To further confirm the role of the latter recep-
tor, we pre-treated THP1 and MDM cells with either ade-
nosine 5'- triphosphate periodate oxidized ATP (oATP);
an irreversible antagonist of P2X7, or an anti-P2X7 block-
ing antibody, before treating with ATP. Autophagy was
completely blocked in the presence of either inhibitor, as
demonstrated by the absence of LC3-II expression in
Western blot gels (Figure 1D), thereby confirming thatBMC Immunology 2008, 9:35 http://www.biomedcentral.com/1471-2172/9/35
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ATP-induced autophagy is mediated via activation of P2X7
receptors.
ATP induced phago-lysosomal fusion in infected 
macrophages is autophagy- dependent
We have previously reported that ATP stimulation of P2X7
promotes acidification of BCG-containing phagosomes
within infected human macrophages [7]. Moreover, it has
also been reported that induction of autophagy in RAW
cells by starvation or treatment with rapamycin was asso-
ciated with acidification and maturation of mycobacterial
phagosomes [4]. In view of these findings, we analyzed
the role of autophagy in ATP-mediated phago-lysosomal
fusion within MDMs infected with green fluorescent pro-
tein expressing M. bovis BCG (GFP-BCG). Lysosomal traf-
ficking was monitored by preloading BCG-infected cells
for 1 hour with the acidotropic fluorescent dye Lys-
otracker Red that accumulates within acidic organelles
[11]. The cells were then stimulated with ATP (3 mM) for
30 minutes. While control non-ATP treated cells showed
Induction of autophagy in THP1 cells and MDMs, following treatment with ATP, is both calcium and P2X7 – dependent Figure 1
Induction of autophagy in THP1 cells and MDMs, following treatment with ATP, is both calcium and P2X7 – 
dependent. A. THP1 cells undergo autophagy (lane 1) following 30 minutes exposure to ATP (3 mM), as revealed by the pres-
ence of LC3-II (16 kDa) by Western blot. Lane 2 represents untreated control THP-1 cells. B. ATP (3 mM) treated MDMs also 
express LC3-II (lane 2), which is absent in non-treated control cells (lane 1). C. THP1 cells treated with 3 mM ATP for 30 min-
utes cultured in calcium-free medium (lane 1) and calcium-replete medium (lane 2). LC3-II expression was observed in ATP-
treated cells cultured in calcium-replete medium (lane 2) but was absent in cells cultured in calcium-free media (lane 1). D. 
THP1 cells were treated with different P2 agonists and antagonists. Lane 1 represents untreated control cells, while lanes 2 and 
3 represent cells pre-treated with oATP (0.3 mM) and anti-P2X7 antibody (3 μg/ml) for 2 hours and 1 hour respectively, prior 
to treatment with ATP (3 mM for 30 minutes). Lanes 4, 5 and 6 represent cells treated with ATP (3 mM), UTP (3 mM) and 
bzATP (3 mM) for 30 minutes. The presence of an LC3-II band, indicating cell autophagy, was observed only in lanes 4 and 6.
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minimal co-localisation of GFP-BCG with Lysotracker Red
labeled lysosomes (7.2 ± 2.5%), there was significantly
greater co-localisation within ATP-treated cells (63.3 ±
4.5%) (p < 0.01; student's unpaired t test) (Figures 2B
&2C). The results confirmed our previously reported find-
ings on the ability of ATP to induce phago-lysosomal
fusion within BCG-infected MDMs [7]. We next examined
whether pharmacological inhibitors of autophagy could
block this effect. We observed that wortmannin, a classical
phospatidylinositol-3 kinase (PI3 Kinase) inhibitor,
which has previously been reported to inhibit the early
stages of autophagosome formation [12], dramatically
reduced the levels of co-localisation of BCG-containing
phagosomes with lysosomes (29.5 ± 3.8%) (p < 0.01; stu-
dent's unpaired t test) (Figures 2B &2C). The results sup-
port the involvement of cell autophagy in ATP-induced,
phagolysosome fusion and acidification of mycobacteria-
containing phagosomes. Pre-treatment of MDMs with an
anti-P2X7 neutralising antibody also resulted in a signifi-
cant reduction in the levels of co-localisation (36.8 ±
5.4%) (p < 0.01; student's unpaired t test) (Figures 2B
&2C).
Localization of mycobacteria in autophagosomes
Electron microscopic analysis of ATP-treated MDMs
revealed the presence of multiple, large cytosolic
autophagic vacuoles within both non-infected and BCG-
infected cells (Figures 3B and 3C), while such vacuoles
ATP-induced autophagy triggers phagosome-lysosome fusion Figure 2
ATP-induced autophagy triggers phagosome-lysosome fusion. A. Confocal images of MDMs treated with 3 mM ATP 
for 30 minutes and immuno stained for intracellular LC3. B. Confocal images of live MDMs infected with GFP-BCG (green) and 
pre-pulsed with Lysotracker (red) to stain acidic lysosomes. Cells were pre-incubated with anti-P2X7 (3 μg/ml) or wortmannin 
(100 nM) for 1 hr and then treated with 3 mM ATP for 30 minutes. Note scale bars = 10 um. C. Graph showing the percentage 
of Lysotracker positive, GFP-BCG containing phagosomes. Histogram shows means ± s.e.m. (n = 25–60 phagosomes). *** = P 
< 0.01.
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were almost absent in non- ATP-treated, infected cells
(Figure 3A). In addition within ATP-treated infected cells,
EM analysis revealed the presence of bacilli within charac-
teristic double-membrane autophagosomes containing
partially degraded internal membranes typical of matur-
ing autophagosomes (Figure 3C &3D) [12-14].
ATP-induced autophagy mediates rapid mycobacterial 
killing
We have previously reported that ATP induces rapid kill-
ing of intracellular mycobacteria via a cell-mediated proc-
ess, as ATP had no direct bactericidal effect on BCG [6]. To
examine the role of autophagy in this process, BCG-
infected MDMs were pre-treated with wortmannin for 1 hr
prior to pulsing with ATP (3 mM) for 30 minutes and the
viability of the intracellular mycobacteria assessed at 2, 4,
and 6 hours post-treatment by 3H-uridinine incorpora-
tion assay (Figure 4). ATP was shown to result in a marked
reduction in intracellular BCG viability at 2 hr (58.6 +/-
6.35%, p < 0.05), 4 hr (45.1 ± 3.7%, P > 0.005) and 6 hrs
post treatment (31.9 +/- 6.2% p < 0.005) as compared to
that obtained in non-ATP-treated, infected cells, confirm-
ing previous reported findings [6]. However, pre-incuba-
tion of infected MDMs with wortmannin for 1 hr prior to
exposure to ATP resulted in marked inhibition of this bac-
tericidal effect with intracellular BCG viability at 2 hrs
Ultrastructural appearance of infected macrophages following exposure to ATP Figure 3
Ultrastructural appearance of infected macrophages following exposure to ATP. A. Electron micrograph of a non-
ATP treated, BCG-infected macrophage showing the presence of the bacteria within phagosomes (BP). B. Exposure to ATP is 
associated with the appearance of numerous double-membrane autophagic vacuoles (AV) within the cell cytoplasm. C. A BCG-
infected human macrophage (MDM) following treatment with 3 mM ATP for 30 minutes, the bacteria localize within 
autophagic vacuoles (AV) with clearly demonstrable inner (double black arrows) and outer (double white arrows) membranes. 
D. A higher magnification image of a number of mycobacteria contained within the inner and outer membranes of an 
autophagic vacuole.
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(76.8+/- 16.1% p < 0.05), 4 hrs (79.7 ± 5.6% p < 0.05)
and 6 hrs (65.5 +/- 4.1%, p < 0.005) remaining signifi-
cantly higher than in equivalent ATP-treated cells at each
time point (Figure 4). To confirm that ATP was acting
through P2X7 to induce cell autophagy, and subsequent
bacterial death, infected MDMs were pre-treated with the
P2X7 receptor antagonist, oATP, for 2 hours prior to expo-
sure to ATP. Pre-treatment of cells with oATP was shown
to result in almost the complete inhibition of ATP-
induced mycobactericidal activity with intracellular BCG
viability at both 4 hrs (97.4 ± 3% p < 0.005) and 6 hrs
(92.9+/- 1.3% p > 0.005) post-treatment remaining simi-
lar to that obtained in non-treated cells, confirming that
ATP acts via P2X7(Figure 4). In total the results suggest
that ATP-induced mycobactericidal activity involves P2X7
activation and the subsequent induction of cell
autophagy.
Discussion
In this study we have shown that ATP-treated, BCG-
infected THP-1 cells and MDMs undergo rapid cell
autophagy, which involves the activation of P2X7 recep-
tors and mobilization of extracellular calcium. Electron
microscopy of ATP-treated, BCG-infected MDMs, revealed
the presence of the bacteria within characteristic double-
membraned autophagosomes. In addition, ATP-induced
The mycobactericidal effect of ATP is reversed by wortmannin and oATP Figure 4
The mycobactericidal effect of ATP is reversed by wortmannin and oATP. MDMs, cultured for 5 days, were 
infected overnight with BCG (MOI of 5:1) and pulsed with ATP (3 mM) for 30 minutes, with or without pre-treatment with 
wortmannin (100 nM/1 hour) or oATP (0.3 mM/2 hours). The kinetics of BCG viability was determined by 3H-uridine incorpo-
ration, monitored at various times post treatment. The figure illustrates the pattern of results obtained from three separate 
experiments performed in triplicate. The symbols indicate mean values, and vertical bars indicate the standard error. The sig-
nificance of the various treatment relative to the untreated control are illustrated by: ** = P < 0.005 * = P < 0.05. The results 
from one 3H-uridine uptake assay are tabulated as mean counts per minute (CPM) data +/- SEM at each time point examined.
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cell autophagy was accompanied by rapid phago-lyso-
somal fusion and loss of mycobacterial viability within
infected cells suggesting that autophagy contributes to this
mycobactericidal process.
Autophagy has recently been highlighted as an innate
immune defense mechanism against bacterial pathogens
such as Group A Streptococcus, Shigella and Mycobacte-
rium tuberculosis [2-5]. Bacterial agents like Listeria
monocytogenes and Staphylococcus aureus have also
been reported to evade host immunity by subverting
autophagy, thereby underscoring its importance as a
potent mycobactericidal mechanism [12,13]. Earlier stud-
ies in rat hepatocytes had shown an association between
reduction in the volume density of autophagic vacuoles
and a fall in intracellular ATP levels [14]. In this study we
sought to obtain more direct confirmation that extracellu-
lar ATP could induce autophagy in human macrophages.
We demonstrated that LC3 lipidation and LC3-II associa-
tion with autophagosomal membranes, which are both
commonly used read-outs of autophagy [9,10], were
induced by ATP, as revealed by immunoblotting and the
transition of LC3 from its diffuse cytosolic appearance to
a punctate intracellular distribution (Figure 1A &1B, Fig-
ure 2A).
Exploring the identity of the purinergic receptor involved
in the process, we observed that ATP-induced autophagy
was mediated via activation of P2X7, as revealed by the use
of specific agonists and antagonists of this receptor.
Autophagy was not induced in the absence of extracellular
calcium (Fig 1c), which was consistent with the known
property of P2X7 to promote influx of extracellular cal-
cium into the cytosol in contrast to P2Y, which mobilize
intracellular calcium.
The highly polymorphic structure of P2X7 has recently
been described and five polymorphisms have been
described that lead to reduction or loss of P2X7 function
[15]. It has recently been shown that P2X7  polymor-
phisms were associated with impaired ATP-induced
mycobacterial killing [16] and increased susceptibility to
extra-pulmonary TB [8]. The present study is the first to
report on the involvement of P2X7  in inducing cell
autophagy and provides a possible rationale for the
impaired mycobactericidal activity and increased predi-
lection for extra-pulmonary TB associated with certain
polymorphic forms of P2X7.
Our laboratory and others have previously reported that
elevation of cytosolic calcium levels in ATP-treated, BCG-
infected macrophages is linked to increased phago-lyso-
somal fusion [7,25]. Since induction of autophagy was
dependent on mobilization of extracellular calcium, we
explored its effect on maturation of mycobacterial phago-
somes. Induction of autophagy by ATP coincided with
increased acidification of mycobacterial phagosomes,
which was reversed on pre-treatment of MDMs with wort-
mannin. In ATP-treated cells, the bacteria were found to
localize within characteristic double-membraned
autophagosomes. A difference in appearance and posi-
tioning of both lysostraker red labeled vesicles and GFP-
BCG within wortmannin treated cells was observed as
compared to anti-P2X7  and non-treated macrophages
(Figure 2B). This was attributed to the previously reported
effect of wortmannin to induce swelling of late endo-
somal compartments associated with PI3-K inhibition
involved in membrane trafficking between late endo-
somes and lysosomes [26,27]. We further observed that
addition of ATP had a bactericidal effect on BCG, which
was reversed partially by wortmannin and almost com-
pletely by oATP (Figure 4). These findings are consistent
with recent observations by Gutierrez et al who demon-
strated that induction of autophagy, by starvation or
rapamycin, in macrophages infected with M. tuberculosis
(Mtb), leads to maturation of mycobacteria-containing
phagosomes into phagolysosomes and suppression of
mycobacterial viability [4]. Hence, induction of
autophagy with ATP, as with the classical inducers like
starvation or rapamycin, can override the mycobacterial
block on phagosomal maturation. This ability of
autophagy to induce phago-lysosomal fusion and subse-
quent bactericidal activity could have potential therapeu-
tic implications. In view of the involvement of P2X7
receptors in this phenomenon, the development of selec-
tive, potent and safe P2X7 agonists as therapeutic alterna-
tives in the treatment of multi drug resistant (MDR)-TB
should be explored.
The bactericidal effect of ATP on BCG or Mtb in human
and bovine MDMs has been reported previously by our
laboratory and other groups [6,17,18], though the mech-
anism of such action has not been clearly elucidated. It
has been recently shown that Mtb infection of macro-
phages leads to intracellular accumulation and extracellu-
lar release of ATP, which in turn activates P2X7 receptors
to mediate cellular apoptosis and bacterial killing [19].
Apoptosis was induced in this latter study in 26.5 ± 2.5%
of macrophages in response to stimulation with 5 mM
ATP at an MOI of 10:1, following 48 hours of infection
[19]. However, the evidence for ATP-induced apoptosis is
still equivocal, as we have found that caspase inhibitors
do not block ATP-mediated killing of intracellular myco-
bacteria although they do block IL-1β release [20]. More-
over, in contrast to ATP, classical inducers of cell
apoptosis such as FasL or anti-Fas antibody are relatively
ineffective at reducing intracellular BCG viability within
infected human macrophages [6,21]. In addition, using a
lower dose of ATP (3 mM), a lower MOI (5:1) and a lower
duration of culture, we failed to observe any difference inBMC Immunology 2008, 9:35 http://www.biomedcentral.com/1471-2172/9/35
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apoptosis levels between ATP-treated and control cells, as
revealed by flow cytometric determination of active cas-
pase-3 expression (data not shown). Though it is probable
that macrophage apoptosis plays a role in ATP-mediated
mycobacterial killing, the rapid decline in intracellular
BCG viability immediately after ATP exposure appears to
be primarily mediated by autophagy. This is consistent
with our observation that wortmannin, a classical inhibi-
tor of autophagy, achieved only partial reversal of bacteri-
cidal activity while the P2X7-antagonist, oATP, almost
completely inhibited ATP-induced bacterial killing (Fig-
ure 4). Similarly, in our confocal studies neither anti-P2X7
or wortmannin treatment completely ablated the co-local-
isation observed following ATP stimulation (Figure 2B
&2C), implying that other mechanisms are involved in
mediating this effect. The results suggest that ATP-induced
mycobactericidal activity is dependent on both autophagy
as well as apoptosis. The use of a more specific P2X7 inhib-
itor such as KN62 or combinations of inhibitors such as
anti-P2X7 and wortmannin, which may exhibit synergistic
activity may help to clarify the relative roles of each proc-
ess. That autophagy is involved in ATP-mediated myco-
bactericidal activity is supported by previous reports
describing profound changes in the architecture of the
intracellular vacuolar system of ATP-treated infected mac-
rophages [[17], our unpublished observations]. However,
these changes were also accompanied by membrane bleb-
bing and nuclear condensation (results not shown),
which are morphological changes associated with early
stages of apoptosis supporting a role for both processes in
the associated mycobactericidal effect. Multiple, large
cytosolic vacuoles were also formed within non-BCG
infected cells following ATP treatment (Figure 3B).
Although no detailed assessment was made of their struc-
ture in terms of whether they represented autophagosome
formation, it was noted that cellular debris was apparent
in a high percentage of them. Our laboratory is currently
undertaking a detailed assessment of such structures to
determine the degree of autophagosome formation
within ATP-treated macrophages.
That autophagy may prove a critical mycobactericidal
effector mechanism utilized by phagocytes is also sug-
gested by the fact that we have previously reported, using
macrophages derived from p47Phox-/- and iNOS-/- mice,
that neither oxygen or nitrogen radical generation are
involved in mediating ATP-induced, mycobactericidal
activity [22]. Moreover, parallel studies performed in
BCG-infected macrophages, derived from both NRAMP
resistant and susceptible strains of mice, also failed to
reveal any influence of this additional macrophage-asso-
ciated, anti-bacterial mechanism on the mycobactericidal
effects of ATP [22]. Thus many of the classical, cell-medi-
ated, antibacterial effector mechanisms of oxygen and
nitrogen radical generation, or Nramp protein expression
do not appear to be involved in, and hence as effective as
induction of autophagy in the ATP-mediated killing of
intracellular mycobacteria.
Work is currently underway in our laboratory to further
analyze the relative roles played by autophagy and apop-
tosis and their inter-dependence in the mycobactericidal
activity mediated by ATP.
Conclusion
We report that exposure to ATP induces human mono-
cytes/macrophages to undergo rapid cell autophagy,
through a P2X7-dependent mechanism. Induction of
autophagy is associated with augmented mycobactericidal
activity of macrophages, which is mediated through
increased phago-lysosomal fusion of mycobacterial
phagosomes. These results support the importance of
autophagy as an innate, cellular, mycobactericidal mech-
anism and highlight a potential therapeutic role for P2X7
agonists in the treatment of MDR-TB.
Methods
Reagents
ATP, bzATP, oATP, UTP, wortmannin, ethylene glycol-
bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid
(EGTA) and calcium chloride (CaCl2) were purchased
from Sigma (Poole, UK). The rabbit anti-LC3 polyclonal
antibody and anti-rabbit secondary antibody were
obtained from Novus Biologicals and Pierce Biotechnol-
ogy respectively. The anti-P2X7 antibody was a kind gift
from Dr Gary Buell (Geneva Biomedical Research Insti-
tute). Lysotracker Red was purchased from Cambrex Bio-
sciences.
Cells and bacteria
Peripheral blood mononuclear cells (PBMC) were iso-
lated from EDTA blood taken from healthy individuals by
standard Ficoll-Hypaque (GE Healthcare Biosciences) gra-
dient separation. Monocytes were then isolated from the
PBMC by overnight adherence to 75 ml plastic tissue cul-
ture flasks (Corning), washed thrice to remove any non-
adherent cells and resuspended by chilling on ice for 30
mins and pipetting with pre-chilled (4°C) PBS. The
monocytes were washed and re-suspended (2.5 × 106
cells/ml) in RPMI 1640 medium (Life Technologies, Pais-
ley, U.K.) containing 5% pooled AB+ male human serum
(First Link, West Midlands, U.K.), 2 mM L-glutamine (Life
Technologies) (complete medium) and rh-GM-CSF (90
IU/ml) (Berlex USA).
THP-1 cells were obtained from the American Type Cul-
ture Collection (Manassas, VA) and cultured in RPMI
1640 medium + 10% fetal calf serum + 2 mM L-
glutamine. The cells were used in a non-activated/differ-BMC Immunology 2008, 9:35 http://www.biomedcentral.com/1471-2172/9/35
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entiated state to maintain their early monocytic pheno-
type.
For experiments using calcium-free media, the cells were
grown in standard Hank's Balanced Salt Solution (HBSS)
or in calcium free HBSS + 2 mM EGTA. The latter was
added to chelate any residual Ca2+.
Stock cultures of M bovis-BCG (Evans strain) were main-
tained in log phase growth in Middlebrook 7H9 broth
(Difco, Detroit, MI) supplemented with 10% Middle-
brook ADC enrichment media (Difco) and 0.02% Tween
(Difco) at 37°C. The concentration of the BCG stock was
determined by direct counting using a Thoma counting
chamber (Weber Scientific UK) under dark ground illumi-
nation.
GFP-BCG was obtained as a kind gift from Prof D. Young
(Imperial College of London, London, U.K). The BCG
contained the gene encoding a FACS-optimized GFP pro-
tein [23] constitutively expressed under the control of the
mycobacterial heat shock protein 60 promoter in a
pSMT3 shuttle vector construct [24]. Stock aliquots,
stored in glycerol at -70°C, were grown to log phase in
7H9 broth supplemented with 10% ADC enrichment
medium, 0.2% Tween 80, and 50 μg/ml hygromycin
(Sigma, St. Louis, MO).
Western blot assay
Following exposure for 30 min to 3 mM ATP, THP1 cells
and blood-derived monocytes were washed once in PBS
and resuspended in RIPA buffer + protease inhibitor
(Sigma, St. Louis, MO) and the cell lysate stored at -80°C
prior to assay. SDS-PAGE was performed using a 15% dis-
continuous gel at 120 V. Following electrophoresis the
resolved proteins were transferred onto a PVDF mem-
brane at 80 V for 60 minutes, using a Biorad transfer appa-
ratus. The blot was removed from the transfer apparatus
and blocked overnight at 4°C in TBS-T, containing 5%
nonfat dried milk. The blot was washed thrice in TBS-T
following overnight incubation and then probed with a
rabbit polyclonal anti-LC3 antibody (diluted 1:1000 in
TBS-T/milk) for 60 minutes. After 3 rinses in TBS-T, perox-
idase-conjugated anti-rabbit secondary antibody was
applied for 1 hour and the excess antibody removed by
washing thrice in TBS-T and the reaction developed using
Supersignal West Pico ECL reagents.
In experiments incorporating purinergic receptor agonist
and antagonists, oATP (0.3 mM) or anti-P2X7 antibody (3
μg/ml) were added to the cells for 2 hr/37°C and 1 hr/
37°C respectively, prior to addition of ATP (3 mM) for 30
minutes/37°C. UTP (3 mM), and bzATP (3 mM) were
similarly added to cells for 30 minutes/37°C before
processing them for western blot analysis for LC3 protein
expression.
Confocal fluorescent microscopy
MDMs were grown to sub-confluence on poly-L-lysine
coated glass-bottom dishes (MatTek) at approximately 5 ×
105 cells/dish for 5 days. GFP-BCG were then added to the
macrophages at an MOI of 5:1 and incubated overnight.
Following removal of extracellular bacteria by multiple
washing, LysoTracker red (75 nM) was added to the cells
for 1 hour at 37°C to stain lysosomes. Wortmannin (100
nM) and anti-P2X7 antibody (3 μg/ml) was then added
for 1 hr at 37°C before addition of ATP (3 mM) in appro-
priate wells. Following exposure to ATP for 30 minutes,
the cells were washed in RPMI. Cells were imaged live
using a Zeiss LSM510 confocal microscope using excita-
tion wavelengths of 488 and 546 nm to visualize GFP and
Lysotracker Red respectively. For LC3 staining, MDMs
were grown on poly-L-lysine coated glass coverslips for 5
days. Following treatment with ATP, cells were fixed with
methanol at -20°C for 30 minutes. Cells were then
washed with PBS and incubated in PBS containing 5%
donkey serum to block non-specific binding. Cells were
incubated with anti- LC3 antibody (1:500) for 1 hour, fol-
lowed by three washes in PBS and treatment with anti-
rabbit secondary antibody, conjugated with AlexaFluor
555 (Invitrogen), for 1 hour. Cells were washed 5 times in
PBS and mounted onto slides with Vectashield (Vector
Laboratories, CA) as a mounting medium. Fluorescence
was visualized by confocal microscopy.
Electron microscopy
Cells were prepared for transmission electron microscopy
(TEM) by pelleting the various cell preparations in 1.5 ml
eppendorfs following centrifugation for 1 min/6000 rpm
in an eppendorf (Hettich) centrifuge. The cell pellets were
then fixed in freshly prepared gluteraldhyde fixative and
stored at 4°C until ready for processing. TEM processing
of the cell samples was performed at the EM microscopy
suite, University of Birmingham according to standard fix-
ation protocols.
BCG viability assay
Macrophages were grown to sub-confluence (approx 5 ×
104cells/well) in 96-well round-bottom microtiter plates
(Corning) at 200 μl/well. A total of 2.5 × 105 BCG per well
was added (MOI 5:1) and incubated at 37°C/5%CO2
overnight. Excess BCG was removed by washing thrice in
RPMI. Where appropriate, wortmannin (100 nM) and
oATP (0.3 mM) were added 1 and 2 hr respectively prior
to addition of ATP (3 mM). Intracellular BCG viability fol-
lowing exposure of infected cells to ATP for 30 min, was
assessed by 3H-uridine incorporation assay as this pro-
vided a much more rapid assessment (within 72 hrs) of
the mycobacterstatic effect of ATP as compared to colonyBMC Immunology 2008, 9:35 http://www.biomedcentral.com/1471-2172/9/35
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forming unit (CFU) assay assessment which takes > 14
days to form countable colonies. The BCG-infected cells
were washed and cultured in RPMI +5%AB+ serum and at
appropriate time points, a total of 150 μl cell supernatant
was removed and transferred to a separate 96 well plate.
Cell lysis was performed on the remaining cell pellets by
addition of 50 ul of a 0.2% saponin solution for 30 min/
37°C. After 30 min, 100 μl of Middlebrook 7H9 (+10%
ADC supplement) was added to each well of both the cell
supernatant and pellet lysates followed by addition of 20
μl/well of a 100 μCi/ml stock of 3H-uridine (Amersham
UK). The wells were harvested after 72 hours on a '1205
betaplate scintillation counter' (Wallac) and the com-
bined counts/min of the matched cell supernatant and
pellet wells were taken as an indicator of relative bacterial
viability.
Statistics
The Student's t-test was used for all statistical compari-
sons.
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